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Abstract 
 
Non-consensual sterilisation is not only a historic abuse. Cases of unethical treatment of 
women around the time of a pregnancy continue in the Twenty-First Century in five 
continents. Sterilisation is being carried out by some healthcare professionals at the time of 
delivery, or soon afterwards, without valid consent. A range of contemporary examples of 
such practices is given. Respecting women's autonomy should be the touchstone of the 
consent process. Avoidance of force, duress, deception and manipulation should go without 
saying. Ethnic minority communities and women living with HIV, in particular, are being 
targeted for this kind of abuse. Attempts have been made in various countries and by 
international professional organisations to introduce clinical guidelines to steer health 
professionals away from this malpractice. Survivors have sought justice in domestic and 
international courts. This paper critically assesses the evidence on the practical, ethical and 
legal issues around the handling of consent for these procedures. Suggestions are made about 
possible regulatory responses that address abuse, whilst maintaining access for those 
individuals who freely elect to undergo these procedures. 
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Introduction 
Historical sterilisation abuses were concentrated in the first four decades of the Twentieth 
Century, particularly in jurisdictions with eugenic laws (Amy and Rowlands, 2018a, 2018b). 
However, abuses on a smaller scale have been identified from 38 countries in the Twenty-
First Century (S. Rowlands and J.-J. Amy, 2018). Respecting women's autonomy should be 
the touchstone of the consent process but there remains ongoing evidence in some countries 
(low-resource through to high-resource) of obstetrician-gynaecologists performing female 
sterilisations in circumstances in which the woman's consent is dubious or invalid (S. 
Rowlands and J.-J. Amy, 2018). There is also evidence that ethnic minority communities, 
women living with HIV and other marginalised groups are being targeted for this kind of 
abuse (Solinger and Nakachi, 2016).  Intersectional attributes or identities – both physical and 
social - may contribute to and feature in these abuses of power and complicate any 
subsequent analysis and regulatory response (Cooper, 2016; Curran, 2016; Sifris, 2016). 
 
This paper examines contemporary evidence about sterilisations carried out on women who 
are being delivered of a baby or immediately thereafter. Our primary focus is on non-
therapeutic surgical intervention, or at least those cases where there is no therapeutic basis for 
intervention in the case of a particular woman (i.e. no medical condition such as fibroids or 
heavy menstrual bleeding is being explicitly treated by the procedure).  All references will 
therefore be to cases where the sterilisation is undertaken solely to control fertility. 
 
This paper is in five parts.  The first part presents Twenty-First Century examples of non-
consensual sterilisation.  In part two, we look at legal and ethical aspects of the issue.  In part 
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three, we examine the positive action that has been taken to date, including the drafting of 
clinical guidelines.  In part four, we suggest possible regulatory responses and in part five we 
draw together our conclusions.   
 
 
 
 
 
 
Contemporary examples 
 
In this part, we have conducted a literature search for non-consensual peripartum female 
sterilisation between the years 2000 and 2017. We identified reports of sterilisation abuses 
around the time of childbirth from five continents. Most of these are not isolated cases, but 
small clusters or larger collections of similar cases. There are doubtless many more examples 
that have gone unreported. We mention here only those examples that have been well-
documented or have been the subject of legal proceedings. These cases demonstrate that the 
women being targeted for sterilisation around the time of delivery frequently belong to  
marginalised population groups (Patel, 2017) or are subject to repressive state control.  
Whilst any suggestion that pregnant women are vulnerable as a class is contentious and 
disputed (Beauchamp and Childress, 2013), the circumstances around and immediately after 
childbirth (for example, ongoing pain) may make some women and groups of women acutely 
vulnerable at this time (FIGO, 2015).  This picture may be further complicated by 
intersectional concerns where the women involved belong to more than one marginalised 
group within a community. 
 
For the avoidance of any doubt, we are not seeking to undermine or diminish women as 
autonomous agents at the time of or around childbirth.  However, we do argue that the 
process of seeking consent requires particular care where the consequences are irreversible 
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and permanent for the women involved.  There may very well be circumstances during or 
after the birth process that undermine the essential requirements of valid consent, including 
the ability to carefully weigh competing alternatives and the advantages/ disadvantages of 
specific courses of action.  Of course, these concerns might apply equally to other types of 
surgical decision-making entailing irreversible, permanent and life changing outcomes.  The 
life changing nature and experiential dimension of the decision-making may prove critical in 
any case (Dunn, Fulford, Herring, & Handa, 2018).  Healthcare professionals should always 
be alert to the fact that sterilisation involves an acutely sensitive and personal decision to give 
up the ability to reproduce. 
 
The actions of health and social care staff in the following cases include violations of the 
right to health, the right to bodily integrity, the right to be free from violence, the right to be 
free from torture and inhuman and degrading treatment, the right to decide on the number and 
spacing of children and the right to be free from discrimination (see Convention on the 
Elimination of All Forms of Discrimination against Women 1979, Article 16).  
 
 
Europe 
Roma women were found to have been disproportionately subjected to non-consensual 
sterilisation at the time of childbirth since the turn of the century in three central European 
countries: the Czech Republic, Hungary and Slovakia (Zampas and Lamačková, 2011). In 
this paper we will take the Czech Republic as our example. In this country there have been 
examples of absent, forged and forced consents for sterilisation in the peripartum period 
(ERRC, 2016).  
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In 2001, a Czech Roma woman aged 19, Helena Ferenčiková, was on the brink of giving 
birth to her second child by caesarean delivery. She was asked by a doctor to give oral 
consent for sterilisation after having been given an alarmist warning that she would die if she 
went through childbirth again; she was already premedicated and the exact timing of this 
'consent' was 31 minutes before surgery (Motejl, 2005). This was invalid consent (Holt, 
2005) by several standards because of the absence of accurate/ correct information, the 
directive nature of the guidance and the presence of premedication.  These create doubt that 
the decision to undertake the procedure was a ‘free and informed’ one.  Ferenčíková sued the 
hospital in the Czech courts for violation of her personal integrity (Zampas and Lamačková, 
2011). She won her case in 2007, the High Court in Olomouc ordering the hospital to provide 
her with a written apology. It was determined that she was not entitled to compensation due 
to the statute of limitation. The Vitkovicka hospital in Ostrava apologised two months later. 
Ferenčíková filed an application to the European Court of Human Rights (ECtHR) regarding 
her lack of compensation and the case is pending. The Czech government has since awarded 
her €10,000 in a ‘friendly settlement’ (ERRC, 2016).  
 
 
North America 
Four indigenous women in the Canadian province of Saskatchewan felt pressurised into 
having sterilisations associated with childbirth during the time period 2005 to 2010 and ‘went 
public’ with their grievances. As a result of extensive publicity, the Saskatoon Health Region 
modified its consent protocols in 2015. An external review was ordered into the 
circumstances of these sterilisations and others who might have been similarly treated were 
asked to come forward (Crozier, 2017). The review was carried out by two well-respected 
and highly-qualified Métis women and was published in July 2017 (Boyer and Bartlett, 
Pre acceptance version 
8 
 
2017). From in-depth interviews of a sample of seven recruited women, it was clear that 
medical staff abused their power and discriminated against Aboriginal women and that the 
women felt powerless. Coercion was relentless over time; saying ‘no’ made no difference. 
The prominent role of social workers in the coercion was exposed. The women spoke of 
deep-seated negative emotional personal impacts, as well as impacts on their relationships 
with their partners. A number of Calls to Action were included at the end of the report. These 
included mandatory cultural training to address false stereotypes such that Aboriginal women 
are incapable of ‘proper’ motherhood or of making their own decisions. The Health Region 
apologised to all the women affected, but no compensation was paid. A class-action was 
started by lawyers in 2017 on behalf of women affected in at least one other Canadian 
province in addition to Saskatchewan (CBC, 2018). 
 
 
South America 
Women living with HIV are particularly targeted by healthcare professionals in Chile; a 2004 
study found that 42% of such women had been sterilised without valid consent (Nair, 2011). 
In particular, there is evidence of coercion of women living with HIV in Chile to have 
sterilisations at the time of delivery (Anonymous, 2010). The case of Francisca, a woman 
living with HIV, was taken to the Inter-American Commission on Human Rights in 2009 by 
the Center for Reproductive Rights and Vivo Positivo. Her case, FS v Chile, is still pending at 
the time of writing (S. Rowlands and J. J. Amy, 2018). Francisca was 20 years old when she 
was sterilised with a complete absence of consent (oral or written – Chilean law requires 
written consent) during a caesarean delivery in Curicó in 2002. In 2007, she filed a complaint 
against the surgeon, but despite a police investigation confirming that she had not given 
consent, the Public Prosecutor dismissed the case. She then exhausted all her domestic 
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remedies in the Chilean court system; an appeal to a higher court was unsuccessful (Nair, 
2011). 
 
 
Africa 
Women living with HIV in Namibia have been sterilised without any consent, coerced into 
consenting in order to be able to access maternity services, asked to consent while in labour, 
given little or no information, not given other options or given a form in a language they do 
not understand. The findings of the 2008 International Community of Women living with 
HIV/AIDS study in Namibia (ICW, 2009) resulted in a government investigation; this found 
no wrong-doing (Nair, 2011). Not content with this outcome, ICW and the Legal Assistance 
Centre filed a total of 16 lawsuits against the Ministry of Health and Social Services as well 
as the three hospitals in question. 
 
In 2012, three of the 16 women living with HIV each sued the Namibian government in the 
High Court (S. Rowlands and J. J. Amy, 2018). All three had been sterilised in public 
hospitals in the mid-2000s at the time of a caesarean delivery. The women alleged violations 
of a range of constitutional rights, lack of valid consent and discrimination based on their 
HIV-positive status. The Namibian High Court ruled that there was evidence that the women 
had been sterilised without valid consent but found insufficient evidence that they had been 
discriminated against because of their HIV status (Badul and Strode, 2013).  
 
The government appealed to the Supreme Court, which upheld the High Court ruling in 2014. 
The Supreme Court judgment, Government of the Republic of Namibia v LM and others 
("Government of the Republic of Namibia v LM and others   
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http://www.saflii.org/na/cases/NASC/2014/19.html ", 2014), was a landmark decision. 
Although the women had signed consent forms for “caesarean section and BTL (abbreviation 
used in the case for bilateral tubal ligation)”, it was ruled that consent could not have been 
valid when (i) the women were in labour, (ii) the procedures had not been properly explained 
to them (use of abbreviations and lack of Oshiwambo interpreters contributed to this) and (iii) 
there was no opportunity to weigh options. The Supreme Court did not find discrimination 
based on HIV status but deplored medical paternalism as specifically harmful to the three 
women in this case and more generally. Legal scholars have suggested that, not only did the 
Court miss an opportunity to consider the human rights implications of forced sterilisation, 
but that a case for gender-based violence should have been mounted by the lawyers acting for 
the women (Durojaye, 2017). 
 
Asia   
Countries with population policies such as China and India (Solinger and Nakachi, 2016), 
whose sterilisations each year number in the millions, will doubtless include many cases of 
non-consensual sterilisation around the time of childbirth, but such cases have hardly ever 
been explicitly reported on. We will therefore confine ourselves to the central Asian republic 
of Uzbekistan.  
 
Under the authoritarian leadership of Islam Karimov, who died in September 2016, very little 
information has reached the outside world. It has been directed, under a confidential internal 
decree dating from 2000, that Uzbek women should be sterilised after they have had two 
children, in order to control the population. The most recent sterilisation campaign in 
Uzbekistan began with decree 1096 of 13 April 2009 which, although not mentioning the 
word ‘sterilisation’, couches its population policy in terms of ‘prophylactic-explanatory work 
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regarding the health of mothers and children’. Contraception and sterilisation is the remit of 
‘dispatch brigades’ sent out to all parts of the country (Antelava, 2013). 
 
Reliable information has been difficult to obtain - usually the source has been interviews with 
individual doctors or women who have undergone sterilisation who are prepared to take the 
risk of speaking out. Reports of forced sterilisations did not emerge until 2005; the existence 
of non-consensual sterilisation is denied by the government (Antelava, 2013). It appears that 
it is mainly doctors rather than lay motivators who recruit acceptors. Subsequently it 
appeared that the Uzbek government set verbal quotas on performance of 'voluntary surgical 
sterilisation'. This involved attempting to secure consent but in most cases women were being 
pressured, deceived or even threatened (Holt, 2012). A woman called 'Nargiza' said that she 
signed a consent form when under the influence of premedication prior to a caesarean 
delivery for her second child; doctors told her the piece of paper was merely a 'thank you 
letter' to the hospital. Sterilisation at caesarean delivery was 'automatic'. It seems individual 
gynaecologists are allocated quotas such as four procedures per month each. Caesarean rates 
have risen, probably as a result of gynaecologists needing to meet their quotas. Women of 
reproductive age coming into hospital for unrelated problems such as appendicitis have also 
been pressured into being sterilised. The issue of forced sterilisations and hysterectomies was 
brought to the attention of the UN committee against Torture in 2007 and again in 2013. 
 
 
Ethical and Legal Aspects 
Having set out a range of contemporary sterilisation abuses, we now move on to consider the 
ethical and legal aspects of valid consent in more detail.  It is a core bioethical principle that 
patients should consent to their medical treatment and that such consent should be both free 
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(voluntary and not unduly influenced, pressured or coerced) and informed (based on 
sufficient and material information with an opportunity for discussion) (Beauchamp and 
Childress, 2013).   This principle presupposes that the primary decision-maker is the patient 
and that they have the capacity to make the relevant choices/ decisions around treatment and, 
in the case of sterilisation, whether to refuse or to consent to that invasive procedure.   
 
Problematic cases 
We have already encountered a range of examples but, for the purposes of discussion, it is 
probably helpful to divide the problematic consent cases into three main categories, although 
we accept that there is some scope for conflation between them. First, there are those cases 
where the healthcare professional performs the medical procedure without any patient 
consent or attempts to obtain it in circumstances where that person does not have the capacity 
to validly consent at the material time.   Secondly, there are those cases where there is an 
issue with the information supplied to the patient, such that the decision-making and consent 
process is based on false or inadequate or incomplete information.  This category can be 
further subdivided, depending on the motives and aims of the information provider.  In this 
specific category, the patient might assert that there was no valid consent to the procedure 
because of the falsity and/or paucity of information, or they might alternatively argue that the 
healthcare professional was simply careless in the supply of information without invalidating 
their consent.  The materiality of the information supplied (or withheld) might tip the balance 
one way or the other. 
 
Thirdly, there are cases where patient agreement to the proposed medical procedure is more 
appropriately framed as one of ‘submission’ – where the agreement has been obtained via the 
use of threats, coercion or other promises to withdraw benefits/ services or impose detriment.  
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The offer of incentives or rewards might also be included here, although this is an even more 
problematic area (Beauchamp and Childress, 2013).   Clearly, there will be examples where it 
is difficult to separate the ‘free’ from the ‘submission’ case, recognising that subtle forms of 
social pressure exist in all aspects of our lives that cannot be entirely excluded from the 
decision-making process.  Healthcare professionals may think it important to advance or even 
exaggerate the merits of a procedure which they genuinely believe is in the best interests of 
their patient.   However, there will come a point when reasonable persuasion crosses the line 
into improper coercion.  Although we may have clear intuitive responses to many of the 
examples in this paper, it can still be difficult to draw a clean bright line between proper and 
improper pressure in certain cases.  However, as we shall see, certain features of sterilisation 
may help point the way.  Finally, it is important to recognise the subjective nature of patient 
responses to pressure and persuasion – the critical issue is whether healthcare professionals 
are acting in a way that undermines the self-autonomous and directed decision-making of the 
patient (Beauchamp and Childress, 2013).  Mutual trust is important to the therapeutic 
relationship and requires professionals not to abuse their social authority and to ensure that 
patient autonomy is respected.  Healthcare professionals are important guardians of this 
autonomy – a position which imposes an ethical obligation requiring specific recognition of 
the potential vulnerability sketched out above.   Clinicians should exercise considerable care 
around the obtaining and implementation of consent to sterilisation during and immediately 
after childbirth.  Circumstantial features - including ongoing pain (FIGO, 2015) and 
intersectional attributes - also need to be weighed in the balance when deciding whether a 
woman is capable of making a free and informed decision, taking into account the gravity 
and nature of the choice/ procedure concerned. 
 
Some preliminary considerations 
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Before going any further, it might be helpful to highlight a few preliminary considerations 
around consent for female sterilisation. The issue of capacity is potentially problematic for a 
woman in the final stages of pregnancy and its immediate aftermath.  She may be in 
considerable pain and using central nervous system depressant medication for this.  There 
may be considerable anxiety over the welfare of the unborn or born child, as well as anxiety 
about her own wellbeing.  Capacity is decision-specific and subject to fluctuation - there may 
be some variance around the capacity to consent to short-term options (e.g. medication, mode 
of delivery) and longer term and potentially irreversible decisions impacting on fertility.  
Again, we should make it clear that we are not suggesting that women do not have the 
capacity to make any decisions around or after childbirth – rather that certain type of 
decisions (those with permanent, life-changing and acutely personal outcomes) require 
healthcare professionals to take particular care to ensure that the patient has the necessary 
capacity and understanding to make a decision of that specific nature (including its 
permanent outcome). This needs to be borne in mind when the medical need is non-urgent, 
even if there are or may be potential benefits for the woman in acting immediately (e.g. 
because it will avoid a second operation).  However, it is equally important that healthcare 
professionals should not be using patient capacity as a guise or contriving ‘therapeutic’ 
grounds – whether motivated by best interests or otherwise - to override the ‘free’ or 
‘informed’ elements of consent (Beauchamp and Childress, 2013).   
 
Sterilisation procedures are usually irreversible and therefore create a permanent outcome for 
the woman.  The availability of reversible and reliable alternatives of contraception may be 
an appropriate and material consideration for patients and clinicians.   These options should 
not be imposed on a woman, any more than sterilisation should, but they ought to be outlined 
as a viable choice before any action is taken that produces a permanent state of affairs.   
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Fertility-focused sterilisation procedures are also by their very nature non-urgent (elective) – 
healthcare professionals cannot justify these interventions purely on necessity grounds 
because ‘best interests’ are not sufficient to sidestep patient consent when there is no medical 
emergency.  This is an important factor when coupled with the permanency and life-changing 
nature of the procedure.  The right to reproduce and to avoid pregnancy (and information 
thereto) is a fundamental human right - one that goes to the core of our humanity - and any 
deprivation of that right demands careful and specific justification by a State and/or its agents 
(see Convention on the Elimination of All Forms of Discrimination against Women 1979, 
Article 16).  Sterilisation not only removes a person’s reproductive capability but may also 
create a stigma or create a value judgement on their worth within society.  We must always 
be alert to the potential discriminatory effects of female sterilisation, especially for 
marginalised groups and those with intersectional identities/ attributes (Cooper, 2016). 
 
We should pause here to address academic and representative body arguments that non-
therapeutic postpartum sterilisations should be categorised as emergency/ urgent procedures 
(Richardson, Hall, & Zuckerwise, 2018).  It is acknowledged that there may be hurdles for 
women to overcome – including funding and insurance requirements - before they can secure 
access to a postpartum sterilisation.  Whilst it might be advantageous to categorise these 
types of procedures as ‘urgent’ for funding or access purposes, the core problem is the 
funding/ access arrangements themselves. It is also artificial to categorise an entire class of 
medical procedures based on speculative consequences.  However, the real issue is that 
categorising postpartum sterilisations as urgent (irrespective of factual need) creates the 
opportunity for clinical abuse.  Converting or categorising non-urgent procedures into ‘urgent 
ones’ for access or funding purposes, sets up an environment for healthcare professionals to 
Pre acceptance version 
16 
 
override or otherwise abuse default consent processes. In our view, the better solution is to 
address the access or funding arrangements directly rather than by shoehorning procedures 
into artificial categories. 
 
Finally, we should not ignore the potential for patient regret after sterilisation.  This regret 
may well be exacerbated if the woman has not been involved in a free and informed consent 
process (Chi and Jones, 1994; Clinical Effectiveness Unit, 2014).  However, it is arguable 
that regret is the wrong term to use for an aggrieved woman in whom the consent or consent 
process was defective (Denbow, 2015).  Of course, regret is not unique to sterilisations but, 
again, the acutely personal and life-changing nature of the interference is an important factor.  
Further, we must always be careful to differentiate between situational regret (about external 
factors motivating a treatment decision that are beyond the control of the healthcare 
professional) and decisional regret (where the patient wishes, with the benefit of hindsight, 
that they had made a different decision) (Watson, 2014).  It is decisional regret which 
healthcare professionals can influence and learn from. 
 
Ethical arguments 
Having sketched out this background, let us move on to develop the specific ethical 
arguments around the handling of consent in sterilisation.   It is important to emphasise that 
bioethical discourse ought to take cultural differences into account, and to recognise that 
different societal priorities and perspectives may be placed on concepts of autonomy.  
However, we also need to make it clear that differential prioritisation of autonomy should not 
be used simply as an excuse to promote discriminatory practices against vulnerable sections 
of society including (for our purposes) some pregnant women. 
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Deontological ethical approaches – that hold that doing the right thing entails that one should 
respect the rights of fellow agents, or that one should act in accordance with one’s duties to 
self and others – generally underpin the value and importance of informed consent prior to 
and during the procedure.  Imposing sterilisation without valid consent clearly impinges upon 
a patient’s right to self-determination and ignores the reciprocal duties that are owed by 
doctors to their patients to promote and ensure autonomous treatment.  For the sake of 
transparency, our own personal emphasis is clearly on respecting individual autonomy in the 
consent process. 
 
Teleological ethical approaches – that hold that one should act in whichever way promises to 
promote some desirable ‘state of affairs or good’, such as general welfare or utility – may 
prioritise principles of beneficence (whether they be patient-centric or more generalised 
concepts of societal benefit) over autonomy.  We have already encountered these ethical 
approaches when discussing intersectionality (which it has been argued has a ‘teleological 
aim to expose and dismantle dominant systems of power’ (Cooper, 2016)) and the 
categorisation of postpartum sterilisation as an urgent procedure (by drawing upon wider 
concern about unintended consequences, access and funding concerns (Richardson, et al., 
2018)). This form of ethical discourse offers the greatest scope to minimise the importance of 
patient choice, personal autonomy and consent.  However, we have already seen the 
limitations of the ‘necessity’ type argument with capable decision-makers in a non-
emergency scenario.  Where best interest arguments are deployed, they can have little to do 
with promoting individual patient welfare and be more about the promotion or alleviation of 
generalised social or resource factors (Richardson, et al., 2018).  There are certainly social 
welfare points that can be made to support expedited sterilisation procedures.  A single 
operative procedure may be a prudent use of scarce medical resources in low-resource States 
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and assist patient access.  However, we should be careful not to confuse or conflate the 
arguments for the fair allocation of public health service resources with the non-consensual 
imposition of those services.  In low-resource countries, maternal mortality and morbidity are 
high and women from rural communities may present to a medical facility for delivery only, 
giving just a single window of opportunity for peripartum sterilisation. Some argue that this 
factor alters the balance of what is ethical, when a missed opportunity to perform sterilisation 
might be followed later by a maternal death (D. A. A. Verkuyl, 2015).   However, it is 
problematic to use a potential risk of harm to justify an actual harm to that individual.   
Whether these or other factors can ever be sufficient to override the requirement of valid 
consent in the competent patient is moot (it is certainly not a position that we endorse); such 
cases and any supporting policies would need very careful and weighty justification by a 
State and its agents.  Further, even where there is public support, ‘paternalistic governmental 
policies or healthcare practices are susceptible to abuse if they lack high-level public 
scrutiny’ (Beauchamp and Childress, 2013). So, for the avoidance of any doubt, we are 
deeply suspicious and/or cautious about the use of teleological ethical approaches that 
undermine patient autonomy in the sterilisation context. 
 
For the sake of completeness, we should also address the Beauchamp and Childress 
'principilism' model that articulates a hybrid ethical approach, and which has been and 
continues to be popular in the healthcare field.  Their principles of autonomy and justice are 
usually associated with deontological ethics, whilst beneficence and non-maleficence are 
more usually associated with teleological ethics.  The irreversibility of sterilisation - a plain 
harm to the competent patient and in our view a breach of personal autonomy when 
undertaken without consent - makes non-therapeutic intervention difficult to justify on 
beneficence grounds alone, particularly where there is reasonable scope to seek that 
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permission.   The ethical principle of justice can be interpreted in many ways, but when 
framed in consequential, distributive and economic terms may provide a means to undermine 
the requirement of valid consent, although it would still need to be balanced against the other 
core ethical principles in the Beauchamp and Childress model.  It would also need to take the 
vulnerability and potential discrimination against the group(s) involved into account.  This 
may strengthen the argument that State actors and healthcare professionals should bear a 
heavy burden in justifying any interference with the requirement for consent in these non-
urgent and potentially irreversible procedures (Beauchamp and Childress, 2013).    This does 
not mean that healthcare professionals should be compelled to act in circumstances which 
they do not regard as being in the patient's best interests.  If they genuinely believe that 
sterilisation is in a patient’s best interests, but valid consent is not forthcoming, there may be 
an obligation to refer that patient to another professional if they do not feel able to respect the 
patient’s wishes. 
 
Having highlighted the central importance of respect for individual autonomy in the consent 
process, we now move on to consider the specific legal responses that might need to be 
addressed by State actors in the context of sterilisation. 
 
Specific legal responses 
Legal consent processes can be helpful – they can be used by healthcare professionals to 
demonstrate that there has not been any deception, coercion or manipulation on their part 
(Manson and O’Neill, 2007).  Different types of law (civil or criminal) may be enacted that 
address the effect and impact of consent in varying ways.  For example, States may wish to 
limit the ability of individuals to consent to certain levels of harm by use of the criminal law.  
This may be subject to exceptions depending on the nature of the actor, the nature of their 
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actions and their overriding motives.  States may want to differentiate consensual invasive 
surgery that is deemed proper medical treatment from lay individuals who choose to inflict 
consensual pain and injury for mutual personal pleasure (Fovargue and Mullock, 2016).  
Whether such distinctions can be ethically maintained is another matter.   
 
Again, States may want to set requirements around what constitutes adequate informed 
consent – what level of information should be disclosed and in what form? So, the law might 
require disclosure of all material benefits/ risks and alternative treatment options (e.g. 
information about the availability of reversible forms of contraception) to be conveyed to the 
patient in a timely fashion before securing consent and the undertaking of any sterilisation 
procedure.   
 
Other practical considerations for the law to address might include: 
 The appropriate allowance for changes of mind and withdrawal of consent (Gilliam, 
Davis, Berlin, & Zite, 2008). 
 The appropriate time intervals between imparting information and obtaining consent 
and then between the consent and the operation (Soares and Brollo, 2013).  A balance 
will need to be struck to ensure that any interval does not unduly fetter patient access. 
 The use of standardised written consent forms and the appropriate literacy levels  
employed (Zite and Wallace, 2011).  The avoidance of medical jargon (Clements, 
2005) and abbreviations. Arrangements that address language and communication 
difficulties or issues (Hunt and de Voogd, 2007). 
 The appropriate allowances for cultural differences (Gostin, 1995).  
 The appropriate mechanisms for identifying hidden forms of pressure – for example, 
from within the family. 
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 The appropriate mechanisms for patient complaints and to address national policies 
that might put pressure on health care professionals to act in a particular way. 
 
 
Positive Action to Date 
In this part, we examine the positive steps that have already been taken to address the abuse 
of consent in female sterilisation.  We offer both international (WHO/ FIGO) and domestic 
(US) guidance as examples. 
 
Human rights bodies have called upon States to take all appropriate measures to prevent 
coercion in relation to fertility and reproduction and to provide effective remedies when such 
violations occur (WHO, 2014). They have specified that these measures may include 
clarifying and strengthening legal frameworks that clearly define full, free and informed 
consent; ensuring that such measures are well understood among healthcare professionals and 
by the public; and the training of healthcare professionals on patients’ rights (WHO, 2014).  
 
Guidelines on consent for sterilisation have been drawn up by both national and international 
professional bodies, starting several decades ago. A US Federal guideline listing criteria for 
Federal reimbursement of the costs of the procedure was produced in 1978 and came into 
force in 1979 (Petchesky, 1979). The guideline included the following stipulations:  
 the woman must be aged 21 or over 
 no-one who is deemed lacking in mental capacity should be sterilised 
 those in institutions or prisons are only to be sterilised if authorised by a court or 
review committee 
 a 30-day waiting period must be observed between consent and the procedure 
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 the consent should not be obtained when a woman is vulnerable such as when 
requesting an abortion, going into labour or in the aftermath of delivery 
 the consent form to be written in a patient’s primary language; otherwise an 
interpreter to be used if the patient cannot understand the language of the consent 
form 
 written confirmation should be given to a woman that she will not have her welfare 
benefits cancelled if she declines the procedure 
 hysterectomy is not considered to be a valid form of fertility control 
 
The International Federation of Gynecology and Obstetrics agreed in March 2011 that the 
following further points are essential to observe when obtaining consent to sterilisation 
(FIGO, 2015): 
 consent must be freely given and adequately informed 
 third parties such as husbands, parents, legal guardians, doctors and health officials 
cannot give consent on behalf of a woman (the laws of some countries contradict this) 
 consent must not be a condition to access to treatment e.g. for HIV infection, to social 
assistance or to release from an institution 
 it is unethical for healthcare professionals to perform a sterilisation within the 
framework of a government programme where the consent is not voluntary 
 concern about the risks that a future pregnancy might expose a woman to is not a 
valid ground for performing a sterilisation 
 it must be explained that sterilisation is permanent and that reversible alternatives are 
available 
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We should highlight two immediate issues with this guidance.  First, the US Federal waiting 
period has proved problematic for access and funding purposes (Richardson, et al., 2018).  It 
presumes that decision-making during this period is defective.  Our position is that whilst 
postpartum sterilisation decisions do raise specific issues for the treating healthcare 
professionals, the mere proximity of the birth does not negate the validity of consent by 
default.  Many women will be quite capable of making free and informed decisions about 
their fertility within the 30-day waiting period, providing of course that the other elements of 
valid consent are respected.  In these cases, waiting periods will act as an unwarranted hurdle 
to patient access.  Secondly, whilst the risk of future pregnancy may not be a valid ground for 
undertaking sterilisation without valid consent, it may nonetheless be a reasonable ground for 
a patient to request a sterilisation or otherwise reasonable for a healthcare professional to 
raise the issue in any discussion around options for contraception. 
 
Possible Regulatory Responses 
In this part, we examine a range of general regulatory responses that might be used to address 
continued non-consensual sterilisation abuses.  At the outset, it is important to emphasise the 
need for a balance to be struck by State actors in this area - there is the risk that overly 
protective regulation and unduly cautious healthcare responses may impede women’s access 
to sterilisation.  A Dutch study showed that 78% of women undergoing caesarean delivery 
who would have wanted a combined caesarean delivery and sterilisation missed the 
opportunity to have this because the subject was not raised (D. A. Verkuyl, van Goor, 
Hanssen, Miedema, & Koppe, 2011). A US study found that 48% of women who had had a 
vaginal delivery did not get the sterilisation they had requested antenatally, often because the 
mandatory US 30-day waiting period had not elapsed (Wolfe, Wilson, Hou, & Creinin, 
2017). There is also the need for a balance between the various policy choices available to 
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State actors – what is paramount is that the decision-making process remains patient-centred 
and respectful of maternal autonomy. 
 
International legal instruments (e.g. Convention on the Elimination of All Forms of 
Discrimination against Women, 1979) and medical guidelines (e.g. FIGO, 2015) undoubtedly 
have a valuable role to play in preventing abuse and co-ordinating/ targeting domestic 
regulatory responses.  They can also provide a valuable route of redress where domestic 
mechanisms fail to provide adequate protection and effective remedies for the women 
involved.  However, international mechanisms are usually less effective and immediate than 
domestic forms of regulation and it is therefore imperative that domestic regulatory 
frameworks are clarified and strengthened.  In the following section, we will focus on four 
broad policy approaches (or policy instruments) open to domestic State actors that can be 
used to address continued non-consensual sterilisation abuses. The usual regulatory wisdom 
suggests that multiple policy approaches tend to work better than singular approaches.  
 
Authority 
Authority-based policy responses usually involve ‘hard’ forms of regulation; these can take 
the form of legal or professional regulation and can be framed in negative or positive terms.  
As we have seen, the obvious target for this type of regulation is the information sharing and 
consent processes around the sterilisation procedure (and medical procedures generally).  
Legal mechanisms may be preferable if there is evidence that professional regulation is not 
proving effective or if the professional regulators are out of step on key points.  There is also 
a role for the law in establishing effective forms of redress and remedy in the event that abuse 
does occur.  The relative balance between legal and professional regulation will be a State-
centric decision but our preference would be that measures should be constructed in tandem 
Pre acceptance version 
25 
 
and not in isolation. Legal mechanisms and sanctions may also be preferred when addressing 
and expunging wider discriminatory practices within society. 
 
Mandatory waiting periods have been used in some jurisdictions to provide a space for the 
assimilation of information and unhurried decision-making.  However, as we have seen, these 
approaches can work against individual autonomy (by causing delays and obstructing access 
to care) and be discriminatory if applied against certain groups of patients.  A good example 
of the latter is the Federal application of a waiting period against women in the US Medicaid 
scheme (Borrero, Zite, Potter, Trussell, & Smith, 2013; Moaddab et al., 2015; Richardson, et 
al., 2018). On balance, we do not support the use of mandatory waiting periods because of 
the potential for adverse impact on patient access. 
 
Informational 
It should be recognised that those individuals and groups most at risk of coercion and 
pressure are often those whose access to contraceptive services is also restricted or denied.  
The broad public dissemination of accurate and non-directive educational materials relating 
to sterilisation and other reversible forms of contraception are clearly important and should 
be a priority for State actors. This might include information about how these procedures can 
be accessed and what sort of conditions the women should expect (e.g. waiting periods, 
duration and the need for hospitalisation). Where sterilisation is the preferred option, State 
actors can mandate the form of any consent paperwork. In the USA, a low-literacy Medicaid 
form did lead to better understanding and was generally preferred over the standard form 
(Zite and Wallace, 2011). It is important that informational approaches address the 
intersectional concerns that we have highlighted; State actors have a responsibility to ensure 
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that marginalised groups/ identities receive necessary and accessible information about the 
full range of contraception options available. 
 
Informational policies should also be directed to the healthcare professionals involved – they 
need adequate training and information about sterilisation procedures, alternative treatment 
options and the proper mechanisms for handling and achieving valid patient consent.  Any 
training needs to recognise the importance of patients’ rights, the importance of respecting 
autonomy (WHO, 2014) and the need for consistent assessments of capacity that do not 
exploit pregnant women and which are sensitive to the type of decisions being made (Dunn, 
et al., 2018).  Here, State actors have an important role to play in ensuring equality of access, 
and in combatting and addressing any systemic discrimination against marginalised groups of 
patients. 
 
Organisational 
Organisational policy instruments ought to address domestic access to sterilisation 
procedures.  They would need to ensure that adequate resources are provided to deliver 
sterilisations and to guarantee that, on a practical level, healthcare professionals have 
adequate time and skills to effectively address the consent process.  Again, specific efforts 
should be made to address marginalised groups.  So, for example, where patients do not 
speak the same language as healthcare providers, interpretation services ought to be made 
available within those establishments.  Many private companies now offer this facility, with 
almost immediate connection by telephone to a person speaking a particular language being 
possible. However, even when using skilled interpreters, it has been shown that it can be 
challenging to achieve valid consent in these cases (Hunt and de Voogd, 2007). 
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National and institutional performance targets can be problematic if they result in undue 
pressure on healthcare professionals to carry out sterilisation procedures (Sharma, 2014).  It 
might be legitimate to monitor the number of procedures to inform other policy responses, 
but great care needs to be taken with the use of any performance targets in the context of 
sterilisation.  We would argue that this is especially the case where marginalised groups are, 
or might be, adversely impacted by a target. States need to be alert to the risk of indirect 
discrimination either because of disproportionate impact on a marginalised group and/or 
because those implementing the targets at a local level are likely to be influenced by 
discriminatory factors. 
 
Incentives 
There may be a place for specific incentives that facilitate better access to sterilisation 
procedures – for example, free transport and childcare services for those who live in 
geographically remote areas – but, generally, incentives are problematic if they undermine 
the personal autonomy of specific individuals or vulnerable groups of patients.  The offer or 
promise of consequential benefits for patients who undergo sterilisation is difficult to justify 
and should not be used. 
 
 
Conclusions 
The targeting of marginalised groups of women for sterilisation, for example minority ethnic 
groups or people living with HIV, is discriminatory. The potential vulnerability of some 
pregnant women should be recognised; and some pregnant women have attributes and/or 
identities that make them particularly vulnerable in the context of sterilisation and prey to 
multiple or intersectional discrimination. Active steps need to be taken on the global and 
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domestic stages to address these continuing abuses whilst maintaining access to sterilisation 
for those choosing freely. Even States with a positive track record of respecting patient 
autonomy must not be complacent and should still take steps to ensure that this issue remains 
on the active policy agenda. In this paper, we have identified a range of possible regulatory 
responses that seek to support and facilitate individual patient autonomy and free and 
informed consent.  Whilst priorities will be influenced by local conditions and ethical starting 
points, multi-pronged responses are more likely to gain traction and to affect positive 
regulatory outcomes. 
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